| Name | Golodirsen |
|---|
| Description | Golodirsen (SRP-4053) is a phosphorodiamidate morpholino oligomer (PMO) that specifically targets exon 53 of dystrophin pre-mRNA. Golodirsen can be used for the research of Duchenne muscular dystrophy (DMD)[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Golodirsen specifically targets exon 53 of dystrophin pre-mRNA, resulting in its exclusion from the final mRNA product. Skipping of exon 53 results in restoration of the mRNA reading frame and leads to the production of a partially internally deleted dystrophin protein with intact C and N-terminal regions[2]. |
| References |
[1]. Heo YA. Golodirsen: First Approval. Drugs. 2020 Feb;80(3):329-333. |
| No Any Chemical & Physical Properties |